AIM Hanxin Vaccine

AIM Hanxin Vaccine, a key subsidiary of AIM Vaccine Co., Ltd., is a leading Chinese biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. The company is best known for its recombinant hepatitis B vaccines, maintaining a significant market share in China through its advanced mammalian cell expression systems. Beyond its core hepatitis B portfolio, AIM Hanxin is actively expanding into next-generation vaccine technologies, including mRNA and recombinant protein platforms for respiratory and infectious diseases. The company operates large-scale GMP-certified manufacturing facilities in Dalian, supporting both domestic supply and international expansion efforts.